A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reported a significant reduction in osteoarthritis pain of the knee or hip.
from Reuters: Health https://ift.tt/2R9e1KM
via IFTTT
0 comments: